Product Information

SUMATRIPTAN SUCC 25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2734 per EA under NDC 00378563059. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Aug 10, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUMATRIPTAN SUCC 25 MG TABLET

sumatriptan succinate
$0.2734per EA

Strength

25 mg/1

NDC

00378563059

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SUMATRIPTAN SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077744

FDA Approved

8/10/2009

TE Code

AB

On Market Since

8/10/2009

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SUMATRIPTAN SUCC 25 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 69.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2734 per EA
All-time high$1.1120 (Feb 12, 2014)
All-time low$0.2394 (Sep 23, 2026)
52-week high$0.3193
52-week low$0.2394
Median price$0.7046
Average price$0.6453
Largest weekly change+48.8% (May 22, 2019)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+7.9%

1M

+14.2%

3M

+9.0%

6M

+0.3%

1Y

-14.4%

3Y

-26.1%

5Y

-60.1%

All

-69.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUMATRIPTAN SUCC 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2734 per EA (NDC 00378563059), effective Nov 18, 2026.

How has the price of SUMATRIPTAN SUCC 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 25 MG TABLET has declined 69.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 25 MG TABLET?

Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 25 MG TABLET has ranged from a low of $0.2394 (Sep 23, 2026) to a high of $1.1120 (Feb 12, 2014), with a median of $0.7046 per EA.

Are there cheaper alternatives to SUMATRIPTAN SUCC 25 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN SUCC 25 MG TABLET, is $0.2509 per EA — about 8% below SUMATRIPTAN SUCC 25 MG TABLET.

Who manufactures SUMATRIPTAN SUCC 25 MG TABLET?

SUMATRIPTAN SUCC 25 MG TABLET (NDC 00378563059) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.